SG43242A1 - Method of treating acute myocardial infarction with hirudin and acetylsalicyclic acid in patients not undergoing thrombolytic treatment - Google Patents

Method of treating acute myocardial infarction with hirudin and acetylsalicyclic acid in patients not undergoing thrombolytic treatment

Info

Publication number
SG43242A1
SG43242A1 SG1996006166A SG1996006166A SG43242A1 SG 43242 A1 SG43242 A1 SG 43242A1 SG 1996006166 A SG1996006166 A SG 1996006166A SG 1996006166 A SG1996006166 A SG 1996006166A SG 43242 A1 SG43242 A1 SG 43242A1
Authority
SG
Singapore
Prior art keywords
hirudin
patients
myocardial infarction
acute myocardial
treating acute
Prior art date
Application number
SG1996006166A
Other languages
English (en)
Inventor
Hubert Dr Heinrichs
Charles H Hennekens
Original Assignee
Behringwerke Ag
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag, Brigham & Womens Hospital filed Critical Behringwerke Ag
Publication of SG43242A1 publication Critical patent/SG43242A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
SG1996006166A 1995-03-15 1996-02-29 Method of treating acute myocardial infarction with hirudin and acetylsalicyclic acid in patients not undergoing thrombolytic treatment SG43242A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40526995A 1995-03-15 1995-03-15
US44055695A 1995-05-12 1995-05-12

Publications (1)

Publication Number Publication Date
SG43242A1 true SG43242A1 (en) 1997-10-17

Family

ID=27019016

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996006166A SG43242A1 (en) 1995-03-15 1996-02-29 Method of treating acute myocardial infarction with hirudin and acetylsalicyclic acid in patients not undergoing thrombolytic treatment

Country Status (14)

Country Link
EP (1) EP0732102A3 (de)
JP (1) JPH0920681A (de)
KR (1) KR960033468A (de)
CN (1) CN1141809A (de)
AR (1) AR002968A1 (de)
AU (1) AU711660B2 (de)
BR (1) BR9601024A (de)
CA (1) CA2171509A1 (de)
FI (1) FI961171A (de)
IL (1) IL117485A0 (de)
NO (1) NO961046L (de)
NZ (1) NZ286082A (de)
SG (1) SG43242A1 (de)
UY (1) UY24181A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004262776A (ja) * 2003-02-21 2004-09-24 Teikoku Seiyaku Co Ltd 血管新生促進剤
CA2538366A1 (en) * 2003-09-19 2005-03-31 Kissei Pharmaceutical Co., Ltd. Concurrent drugs
US20060222640A1 (en) * 2005-03-29 2006-10-05 Boehringer Ingelheim International Gmbh New pharmaceutical compositions for treatment of thrombosis
WO2008009638A2 (en) * 2006-07-17 2008-01-24 Boehringer Ingelheim International Gmbh New indications for direct thrombin inhibitors in the cardiovascular field

Also Published As

Publication number Publication date
AU4807296A (en) 1996-09-26
NO961046L (no) 1996-09-16
CN1141809A (zh) 1997-02-05
EP0732102A2 (de) 1996-09-18
KR960033468A (ko) 1996-10-22
IL117485A0 (en) 1996-07-23
UY24181A1 (es) 1996-03-20
AU711660B2 (en) 1999-10-21
FI961171A0 (fi) 1996-03-13
NZ286082A (en) 1998-09-24
JPH0920681A (ja) 1997-01-21
AR002968A1 (es) 1998-05-27
NO961046D0 (no) 1996-03-14
BR9601024A (pt) 1997-12-30
FI961171A (fi) 1996-09-16
EP0732102A3 (de) 1999-01-27
CA2171509A1 (en) 1996-09-16

Similar Documents

Publication Publication Date Title
AR244827A1 (es) Procedimiento para blanquear material celulosico derivado de pulpa quimica y que tiene enlaces xilosidicos hidrolizables por xilanasa y material resultante.
ZA943119B (en) Surface treating articles and methods of making same
PL327312A1 (en) Tricyclic amides useful in inhibiting action of g protecin and in treatment of poliferation-type diseases
ZA961183B (en) Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
EP0719317A4 (de) Nichtkaustische ofenreiniger für niedere temperaturen
EP0292313A3 (en) Method and apparatus for preliminary treatment of stainless steel for cold rolling
GB2283403B (en) Improvements in and relating to treatment of meat
SG43242A1 (en) Method of treating acute myocardial infarction with hirudin and acetylsalicyclic acid in patients not undergoing thrombolytic treatment
JPS6465273A (en) Surface treatment of metal product and surface treated product
AU3571095A (en) Polypeptides and their use in treatment and prophylaxis of auto-immune disease
GB9519737D0 (en) Polypeptides and their use in treatment and prophylaxis of auto-immune
ZA962074B (en) Method of treating acute mycocardial infarction with hirudin and acetylsalicylic acid in patients not undergoing thrombolytic treatment
GB2293604B (en) Dermal fibroblast cells containing muscle-specific DNA and the use of dermal fibroblast cells in the treatment of muscular disorders
GB9110413D0 (en) Improvements in or relating to a treatment and/or a method of treating
PT81774B (pt) Aperfeicoamentos no processo de tratamento de couros e produtos semelhantes ao couro
HUP9702470A3 (en) Method and apparatous for treatment of operation gas in circulating whirl-layer
ZA938599B (en) Treatment of infertility and enhancement of fertilization capacity in mammalian males.
CS275038B2 (en) Method of sewage waters treatment with content of ethylenediaminetetraacetic acid and their above all calcerous complexes
ZA886581B (en) Diagnosis and treatment of double-stranded rna deficiency states
PL293324A1 (en) Method of treating potatoe bulbs to be store and brought into trade turnover and treating line therefor
ZA945567B (en) Water treatment agent and method of its use
IL104735A0 (en) Apparatus and method of treating blood
GB9408914D0 (en) Treatment and pophylaxis of infarction
GB9526317D0 (en) Improvements in and relating to treatment of effluent sludge
PL271674A1 (en) Method of and apparatus for circulation of liquid in biological treatment chamber